You may also like
Should Eligibility for Heart Transplantation be a Requirement for Left Ventricular Assist Device Use? Recommendations Based on a Systematic Review
Left ventricular assist devices (LVADs) are used in chronic end-stage heart failure as "bridge to transplantation" (BTT) and, more recently, for transplant-ineligible patients as "destination therapy" (DT). We reviewed the evidence on clinical effects and cost-effectiveness of 2 types of continuous-flow LVADs (HeartMate II [HM II] and HeartWare), for BTT and DT patients.
1 min read
Recombinant Factor VIIa (NovoSeven) as a Hemostatic Agent After Surgery For Aongenital Heart Disease
We present our experience with rFVIIa treatment for uncontrolled bleeding after open-heart surgery in five pediatric patients.
1 min read
Three-Dimensional Printing in Adult Cardiovascular Medicine for Surgical and Transcatheter Procedural Planning, Teaching and Technological Innovation
We have highlighted different materials used to replicate aortic and mitral valves, vessels and myocardial properties. 3D printing allows a heuristic approach to investigate complex cardiovascular diseases, and it is a unique patient-specific technology providing enhanced understanding and tactile representation of cardiovascular anatomies for the procedural planning and decision-making process.
1 min read